Olin Corp OLN
We take great care to ensure that the data presented and summarized in this overview for OLIN Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding OLN
View all-
Hotchkis & Wiley Capital Management LLC Los Angeles, CA12.2MShares$267 Million1.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$258 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$256 Million0.01% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA6.38MShares$140 Million0.61% of portfolio
-
State Street Corp Boston, MA4.78MShares$105 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.55MShares$99.7 Million0.03% of portfolio
-
Donald Yacktman Yacktman Asset Management LP4.02MShares$88.1 Million1.4% of portfolio
-
Richard Pzena Pzena Investment Management LLC3.66MShares$80.3 Million0.32% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny2.14MShares$47 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA2.01MShares$44 Million0.0% of portfolio
Latest Institutional Activity in OLN
Top Purchases
Top Sells
About OLN
Olin Corporation manufactures and distributes chemical products in the United States, Europe, and internationally. It operates through three segments: Chlor Alkali Products and Vinyls; Epoxy; and Winchester. The Chlor Alkali Products and Vinyls segment offers chlorine and caustic soda, ethylene dichloride and vinyl chloride monomers, methyl chloride, methylene chloride, chloroform, carbon tetrachloride, perchloroethylene, hydrochloric acid, hydrogen, bleach products, potassium hydroxide, chlorinated organics intermediates and solvents, and sodium hypochlorite. The Epoxy segment provides epoxy materials and precursors, including aromatics, such as acetone, bisphenol, cumene, and phenol, as well as allyl chloride, epichlorohydrin, and glycerin used for the manufacturers of polymers, resins and other plastic materials, and water purification; liquid and solid epoxy resins that are used in adhesives, marines, protective coatings, composites, and flooring; and converted epoxy resins and additives for use in electrical laminates, paints and coatings, wind blades, electronics, and construction. The Winchester segment offers sporting ammunition products, including shotshells, small caliber centerfire, and rimfire ammunition products for hunters and recreational shooters, and law enforcement agencies; small caliber military ammunition products for use in infantry and mounted weapons; and industrial products comprising gauge loads and powder-actuated tool loads for maintenance applications in power and concrete industries, and powder-actuated tools in construction industry. The company markets its products through its sales force, as well as directly to various industrial customers, mass merchants, retailers, wholesalers, other distributors, and the U.S. Government and its prime contractors. Olin Corporation was incorporated in 1892 and is based in Clayton, Missouri.
Insider Transactions at OLN
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 17
2025
|
Deon Carter VP & President CAPV |
SELL
Payment of exercise price or tax liability
|
Direct |
609
-24.36%
|
$12,180
$20.04 P/Share
|
Jun 17
2025
|
Deon Carter VP & President CAPV |
BUY
Exercise of conversion of derivative security
|
Direct |
2,500
+50.0%
|
-
|
Jun 01
2025
|
Florian J Kohl VP & Pres,Epoxy&International |
SELL
Payment of exercise price or tax liability
|
Direct |
305
-24.4%
|
$5,795
$19.63 P/Share
|
Jun 01
2025
|
Florian J Kohl VP & Pres,Epoxy&International |
BUY
Exercise of conversion of derivative security
|
Direct |
1,250
+50.0%
|
-
|
May 01
2025
|
Beverley A Babcock Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,757
+43.94%
|
$57,897
$21.77 P/Share
|
May 01
2025
|
Carol A Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,378
+14.78%
|
$28,938
$21.77 P/Share
|
Feb 19
2025
|
Todd A Slater VP & CFO |
BUY
Grant, award, or other acquisition
|
Direct |
3,482
+2.14%
|
-
|
Feb 19
2025
|
R Nichole Sumner VP & Controller |
BUY
Grant, award, or other acquisition
|
Direct |
715
+2.81%
|
-
|
Feb 19
2025
|
Teresa M Vermillion VP & Treasurer |
BUY
Grant, award, or other acquisition
|
Direct |
691
+3.96%
|
-
|
Feb 19
2025
|
Dana C. O'Brien SVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,098
+50.0%
|
-
|
Feb 19
2025
|
Brett A Flaugher VP & Pres, Winchester |
BUY
Grant, award, or other acquisition
|
Direct |
1,845
+50.0%
|
-
|
Feb 04
2025
|
Kenneth Todd Lane President & CEO |
BUY
Open market or private purchase
|
Direct |
7,250
+50.0%
|
$203,000
$28.06 P/Share
|
Nov 08
2024
|
R Nichole Sumner VP & Controller |
SELL
Open market or private sale
|
Direct |
10,500
-30.39%
|
$451,500
$43.75 P/Share
|
Nov 08
2024
|
R Nichole Sumner VP & Controller |
BUY
Exercise of conversion of derivative security
|
Direct |
10,500
+23.3%
|
$283,500
$27.4 P/Share
|
May 01
2024
|
Carol A Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
380
+5.47%
|
$19,760
$52.58 P/Share
|
May 01
2024
|
William H Weideman Director |
BUY
Grant, award, or other acquisition
|
Direct |
761
+5.47%
|
$39,572
$52.58 P/Share
|
May 01
2024
|
Julie A Piggott Director |
BUY
Grant, award, or other acquisition
|
Direct |
761
+50.0%
|
$39,572
$52.58 P/Share
|
May 01
2024
|
Beverley A Babcock Director |
BUY
Grant, award, or other acquisition
|
Direct |
761
+50.0%
|
$39,572
$52.58 P/Share
|
Feb 27
2024
|
Scott Mc Dougald Sutton President & CEO |
SELL
Open market or private sale
|
Direct |
48,896
-6.93%
|
$2,542,592
$52.43 P/Share
|
Feb 27
2024
|
Scott Mc Dougald Sutton President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
48,896
+25.99%
|
$1,369,088
$28.99 P/Share
|
Last 12 Months Summary
Open market or private purchase | 7.25K shares |
---|---|
Grant, award, or other acquisition | 13K shares |
Exercise of conversion of derivative security | 14.3K shares |
Open market or private sale | 10.5K shares |
---|---|
Payment of exercise price or tax liability | 914 shares |